Which hedge funds own ANIP? ANI PHARMACEUTICALS INC, Q2 2026 13F holders
45 tracked hedge funds disclosed a position in ANIP (ANI PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $573.6m in total. The largest holder by portfolio weight is Jones Hill Capital LP at 4.1% of its book. 9 opened a new position this quarter: Rubric Capital Management LP, EntryPoint Capital, LLC, Ares Systematic Credit Ltd, ExodusPoint Capital Management, LP. 8 exited: Goldentree Asset Management LP, Deep Track Capital, LP, Aristeia Capital, L.L.C..
- 45
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 9
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 8
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $25.8m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $127m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $574m
- Combined value Sum of the holders' reported positions in the security.
- 3.6%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Goldentree Asset Management LP | 3.0% | $51.3m |
| Deep Track Capital, LP | 1.0% | $46.1m |
| Aristeia Capital, L.L.C. | 0.2% | $9.9m |
| Balyasny Asset Management L.P. | 0.04% | $18.6m |
| Gsa Capital Partners LLP | 0.03% | $504k |
| Lighthouse Investment Partners, LLC | 0.01% | $201k |
| Graham Capital Management, L.P. | 0.01% | $208k |
| Polen Capital | 0.0% | $493k |
Ownership over time
Who discovered ANIP first? Beta
The run: Q4 2013 → Q1 2015, +212%
| Worth Venture Partners, LLC | Q3 2022 | – | +1.1 pts |
| Rubric Capital Management LP | Q2 2023 | – | +1.0 pts |
| Parkman Healthcare Partners LLC | Q4 2021 | – | +0.7 pts |
| Weiss Asset Management LP | Q3 2017 | – | +0.6 pts |
| Mangrove Partners IM, LLC high conviction | Q3 2017 | – | +0.3 pts |
| Perceptive Advisors LLC | Q4 2014 | – | −0.3 pts |
| Stonepine Capital Management, LLC high conviction | Q1 2025 | – | −0.6 pts |
| Hawk Ridge Capital Management LP | Q1 2019 | – | −0.9 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.